Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Maravai Lifesciences Holdings Inc (MRVI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Maravai Lifesciences's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.01 +0.04    +0.45%
06/05 - Closed. Currency in USD ( Disclaimer )
After Hours
9.07
+0.06
+0.67%
17:53:42 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,300,343
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 8.86 - 9.08
Maravai Lifesciences 9.01 +0.04 +0.45%

MRVI Recent Sentiments

 
This page contains information on users’ sentiments for the Maravai Lifesciences Holdings Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 04, 2024 Azazavr   8.44 Apr 04, 2024 @ 8.71 +3.20%
Mar 08, 2024 Евгений Ермаков   7.71 Mar 29, 2024 @ 8.67 +12.45%
Mar 08, 2024 Matthew Earl   7.71 Mar 29, 2024 @ 8.67 +12.45%
Feb 23, 2024 Juan Gamisans   8.23 Feb 28, 2024 @ 8.04 +2.31%
Feb 23, 2024 John Paul Zanartu   7.71 Mar 15, 2024 @ 7.70 -0.13%
Dec 28, 2023 Tomas Simonaitis   6.62 Jan 19, 2024 @ 6.25 -5.59%
Dec 25, 2023 Simon Benninga   6.94 Dec 25, 2023 @ 6.61 -4.76%
Nov 28, 2023 Tomas Simonaitis   5.12 Dec 22, 2023 @ 6.61 +29.10%
Aug 30, 2023 Suhail Dayyeh   10.37 Nov 30, 2023 @ 5.20 -49.86%
Aug 07, 2023 Krisztian Bodis   10.86 Nov 30, 2023 @ 5.20 -52.12%
Aug 02, 2023 Tomasz Olszewski   11.46 Aug 16, 2023 @ 10.38 -9.42%
Jul 18, 2023 Eug Eug   12.58 Nov 30, 2023 @ 5.20 -58.66%
Jul 14, 2023 Олена Вітюк   13.20 Nov 30, 2023 @ 5.20 -60.61%
Jun 15, 2023 Blu Scatto   13.35 Nov 30, 2023 @ 5.20 -61.05%
May 30, 2023 Игорь Рыбочкин   12.31 Nov 30, 2023 @ 5.20 -57.76%
May 09, 2023 Samy Ould kaddour   12.74 Nov 30, 2023 @ 5.20 -59.18%
Feb 02, 2023 Malwi Hassan Aldeeb   15.54 Feb 24, 2023 @ 14.36 -7.59%
Jan 18, 2023 MadeForStreets   14.46 Jan 31, 2023 @ 14.66 +1.38%
Jan 13, 2023 Serkan Adibatmaz   13.59 Jan 16, 2023 @ 13.83 +1.77%
Dec 22, 2022 Maiken Mr   14.04 Jan 13, 2023 @ 13.83 -1.50%
Dec 13, 2022 Brewtus Hawthorn   14.04 Jan 06, 2023 @ 13.17 -6.20%
Nov 25, 2022 Aidos Almuratov   14.28 Dec 16, 2022 @ 14.79 -3.57%
Nov 22, 2022 Timur Yessengaliyev   14.28 Dec 16, 2022 @ 14.79 +3.57%
Nov 11, 2022 Alex Ch   15.65 Nov 14, 2022 @ 15.32 +2.11%
Oct 27, 2022 Simon Benninga   16.12 Nov 18, 2022 @ 14.48 -10.17%
Oct 19, 2022 Александр Аникеев   16.93 Nov 11, 2022 @ 15.73 -7.09%
Oct 11, 2022 יוסף אזולאי   18.11 Nov 04, 2022 @ 15.51 -14.36%
Sep 16, 2022 zt omo   22.99 Oct 07, 2022 @ 19.74 -14.14%
Sep 13, 2022 Alex Ch   22.69 Sep 19, 2022 @ 22.90 -0.93%
Aug 31, 2022 Валентин Качан   21.01 Sep 05, 2022 @ 20.87 -0.67%
Aug 29, 2022 Alex Ch   22.05 Sep 05, 2022 @ 20.87 +5.35%
Aug 26, 2022 Мая Амарян   22.93 Aug 29, 2022 @ 21.78 -5.02%
Aug 23, 2022 Viktor Mikheyev   23.56 Sep 16, 2022 @ 23.30 -1.10%
Jul 06, 2022 Олександр Семенченко   29.02 Jul 29, 2022 @ 26.09 -10.10%
Jun 01, 2022 Ulises Va   30.97 Jun 24, 2022 @ 28.45 -8.14%
May 13, 2022 Yair Haza   33.51 Jun 03, 2022 @ 32.55 -2.86%
Apr 29, 2022 Eric Bengts   30.18 May 20, 2022 @ 33.58 +11.27%
Apr 21, 2022 Arman Kala   35.97 May 13, 2022 @ 33.54 -6.76%
Mar 30, 2022 Валентин Качан   36.80 Apr 04, 2022 @ 35.55 -3.40%
Mar 15, 2022 David De Munter   37.30 Apr 08, 2022 @ 37.48 +0.48%
Mar 07, 2022 Israel Veleces   38.51 Mar 16, 2022 @ 39.81 +3.38%
Feb 28, 2022 Hakan Bulut   38.95 Mar 25, 2022 @ 36.40 -6.55%
Feb 22, 2022 Jamil Kraidieh   33.95 Mar 18, 2022 @ 40.92 -20.53%
Feb 18, 2022 Anton Vostrepkin   32.12 Feb 18, 2022 @ 32.12 0.00%
Feb 14, 2022 MadeForStreets   29.30 Mar 11, 2022 @ 38.16 +30.24%
Jan 21, 2022 Dionte Edwards   24.95 Jan 23, 2022 @ 0.00 0.00%
Jan 21, 2022 Dionte Edwards   24.95 Jan 23, 2022 @ 0.00 0.00%
Dec 03, 2021 Александр Чибисов   41.87 Dec 24, 2021 @ 42.00 -0.31%
Nov 29, 2021 avraham levi   43.89 Dec 06, 2021 @ 39.89 -9.11%
Nov 15, 2021 יוסף אזולאי   37.61 Dec 10, 2021 @ 39.47 +4.95%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRVI Comments

Write your thoughts about Maravai Lifesciences Holdings Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Abanoub Mohsen
Abanoub Mohsen Oct 11, 2021 2:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happens with this stock
Abanoub Mohsen
Abanoub Mohsen Oct 11, 2021 2:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Only down
Юрий Букин
Юрий Букин Mar 03, 2021 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$MRVI Maintains KeyBanc Overweight USD 39 » USD 46 Maintains Credit Suisse Outperform USD 34 » USD 42
Юрий Букин
Юрий Букин Mar 02, 2021 5:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's a rocket! Revenue of $98.4 million for the fourth quarter and $284.1 million for the full year of 2020, representing 173.5% and 98.5% increases, respectively, over the corresponding periods of 2019; Net income (loss) and Adjusted EBITDA was $78.8 million and $169.2 million, respectively, for the year ended December 31, 2020, compared to $(5.2) million and $62.0 million, respectively, for the prior year. Established 2021 revenue guidance of $580.0 million to $630.0 million, representing growth of 104.2% to 121.8%. https://finance.yahoo.com/news/maravai-lifesciences-reports-fourth-quarter-210500901.html
Юрий Букин
Юрий Букин Feb 18, 2021 2:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why does no one talk about this company? The company has more than 5 thousand clients, including 20 leading world biopharmaceutical companies (including those testing anti-Covid drugs). For 9M2020, revenues was at $186m vs $143m for the whole 2019 ($124m for 2018); Net profit for 9m2020 was at $64m vs net loss of $5m for the whole 2019 (-$17m for 2018). I suppose it should demonstrate great results for YE2020 on March 2 - demand for its products from pharmaceutical companies should be high. => Bullish
Very Long
Very Long Feb 02, 2021 4:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Am I the only one who sees EUR/USD page instead of MRVI
casey kc
casey kc Feb 02, 2021 4:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No. Same here.
Very Long
Very Long Feb 02, 2021 4:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is this page always broken
Paco Bv
Pacob Dec 01, 2020 10:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV™, Sterling™, Glen Pak™, Glen Gel-Pak™, Poly-Pak™, VECTASTAIN® and VECTASHIELD®.
Mukhtar Zhangabylov
Mukhtar Zhangabylov Nov 25, 2020 6:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
mthfk...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email